KÖHM, Michaela, MCINTOSH, Matthew J., HOFMANN, Michael Werner, ABRAHAM, Varghese, GABAY, Cem, CHOY, Ernest H., KAVANAUGH, Arthur, BURKHARDT, Harald und BEHRENS, Frank, 2020. Individual therapeutic DAS28-dcrit responses differentiate between effectiveness of rheumatoid arthritis therapies and reflect patient-reported outcomes: retrospective analysis of DAS28 responses in comparative tocilizumab studies. Berlin: Springer.
Elsevier - Harvard (with titles)Köhm, M., Mc Intosh, M.J., Hofmann, M.W., Abraham, V., Gabay, C., Choy, E.H., Kavanaugh, A., Burkhardt, H., Behrens, F., 2020. Individual therapeutic DAS28-dcrit responses differentiate between effectiveness of rheumatoid arthritis therapies and reflect patient-reported outcomes: retrospective analysis of DAS28 responses in comparative tocilizumab studies, Rheumatology international. Springer, Berlin. https://doi.org/10.1007/s00296-020-04514-7
American Psychological Association 7th editionKöhm, M., Mc Intosh, M. J., Hofmann, M. W., Abraham, V., Gabay, C., Choy, E. H., Kavanaugh, A., Burkhardt, H., & Behrens, F. (ca. 2020). Individual therapeutic DAS28-dcrit responses differentiate between effectiveness of rheumatoid arthritis therapies and reflect patient-reported outcomes: retrospective analysis of DAS28 responses in comparative tocilizumab studies [Cd]. In Rheumatology international. Springer. https://doi.org/10.1007/s00296-020-04514-7
Springer - Basic (author-date)Köhm M, Mc Intosh MJ, Hofmann MW, Abraham V, Gabay C, Choy EH, Kavanaugh A, Burkhardt H, Behrens F (2020) Individual therapeutic DAS28-dcrit responses differentiate between effectiveness of rheumatoid arthritis therapies and reflect patient-reported outcomes: retrospective analysis of DAS28 responses in comparative tocilizumab studies. Springer, Berlin
Juristische Zitierweise (Stüber) (Deutsch)Köhm, Michaela/ Mc Intosh, Matthew J./ Hofmann, Michael Werner/ Abraham, Varghese/ Gabay, Cem/ Choy, Ernest H./ Kavanaugh, Arthur/ Burkhardt, Harald/ Behrens, Frank, Individual therapeutic DAS28-dcrit responses differentiate between effectiveness of rheumatoid arthritis therapies and reflect patient-reported outcomes: retrospective analysis of DAS28 responses in comparative tocilizumab studies, Berlin 2020.